Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy

Conclusion: Clinically significant plexopathy was not seen in spite of majority having over 2-years follow-up and a third of patients having dose above the recommended tolerance. Only nodal category independently influenced dose to the brachial plexii.

Source: Journal of Cancer Research and Therapeutics - May 28, 2019 Category: Cancer & Oncology Authors: Bhanu B Prakash Prahlad H Yathiraj T Krishna Sharan Anshul Singh Anusha S Reddy Srinidhi G Chandraguthi Ramya Bala Subramanian Jyothi Nagesh Sarath S Nair Donald J Fernandes Vidyasagar S Mamidipudi Source Type: research